Cargando…

Occurrence of hepatotoxicity with pazopanib and other anti-VEGF treatments for renal cell carcinoma: an observational study utilizing a distributed database network

PURPOSE: To quantify the hepatic safety of pazopanib and comparator anti-vascular endothelial growth factor (VEGF) therapies in clinical practice among renal cell carcinoma (RCC) patients. METHODS: A population-based cohort study of new anti-VEGF users was conducted in two US healthcare databases, D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shantakumar, Sumitra, Nordstrom, Beth L., Djousse, Luc, Hall, Susan A., Gagnon, David R., Fraeman, Kathy H., van Herk-Sukel, Myrthe, Chagin, Karen, Nelson, Jeanenne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010603/ https://www.ncbi.nlm.nih.gov/pubmed/27438066 http://dx.doi.org/10.1007/s00280-016-3112-9

Ejemplares similares

Prescriber Compliance With Liver Monitoring Guidelines for Pazopanib in the Postapproval Setting: Results From a Distributed Research Network
por: Shantakumar, Sumitra, et al.
Publicado: (2019)

Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases
por: Landis, Sarah H., et al.
Publicado: (2013)

Incidence of New-Onset Hypertension in Cancer Patients: A Retrospective Cohort Study
por: Fraeman, Kathy H., et al.
Publicado: (2013)

Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis
por: van Herk-Sukel, Myrthe P. P., et al.
Publicado: (2012)

Pazopanib and anti-VEGF therapy
por: Drabkin, Harry A
Publicado: (2010)

Characterization and burden of severe eosinophilic asthma in New Zealand: Results from the HealthStat Database
por: Shantakumar, Sumitra, et al.
Publicado: (2020)

Use of Erythropoiesis-Stimulating Agents Among Chemotherapy Patients With Hemoglobin Exceeding 12 Grams Per Deciliter
por: Nordstrom, Beth L., et al.
Publicado: (2008)

Delayed nivolumab‐induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case
por: Todo, Maki, et al.
Publicado: (2019)

Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Occurrence of abscesses during treatment with pazopanib in metastatic renal cancer: a case report
por: Puliafito, Ivana, et al.
Publicado: (2020)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
por: Shroff, Rachna T, et al.
Publicado: (2018)

The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
por: Shroff, Rachna T, et al.
Publicado: (2017)

Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors
por: Kummar, Shivaani, et al.
Publicado: (2021)

Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity
por: Choudhury, Yukti, et al.
Publicado: (2017)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

A steep increase in healthcare seeking behaviour in the last months before colorectal cancer diagnosis
por: Kuiper, Josephina G., et al.
Publicado: (2021)

A population‐based linked cohort of cancer and primary care data: A new source to study the management of cancer in primary care
por: Kuiper, Josephina G., et al.
Publicado: (2021)

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study
por: Weberpals, Janick, et al.
Publicado: (2017)

Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study
por: Kuiper, Josephina G., et al.
Publicado: (2018)

Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease
por: Aggarwal, Bhumika, et al.
Publicado: (2018)

Effects of Pazopanib Monotherapy vs. Pazopanib and Topotecan Combination on Anaplastic Thyroid Cancer Cells
por: Di Desidero, Teresa, et al.
Publicado: (2019)

Validation of Claims Algorithms for Progression to Metastatic Cancer in Patients with Breast, Non-small Cell Lung, and Colorectal Cancer
por: Nordstrom, Beth L., et al.
Publicado: (2016)

Risk of heart failure among colon and rectal cancer survivors: a population‐based case–control study
por: Kuiper, Josephina G., et al.
Publicado: (2022)

Pazopanib and Statin-Induced Rhabdomyolysis
por: Logue, Jennifer M., et al.
Publicado: (2017)

Phototoxic Reaction Induced by Pazopanib
por: Udompanich, Siriorn, et al.
Publicado: (2018)

Tension Pneumothorax: Is it Sarcoma or Pazopanib?
por: Sebanayagam, Vinoja, et al.
Publicado: (2020)

Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors
por: Schoormans, Dounya, et al.
Publicado: (2017)

Pazolimus: pazopanib plus sirolimus following progression on pazopanib, a retrospective case series analysis
por: Katz, D., et al.
Publicado: (2016)

Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors
por: Schoormans, Dounya, et al.
Publicado: (2018)

Cardiac dysfunction among soft tissue sarcoma patients in Denmark
por: Shantakumar, Sumitra, et al.
Publicado: (2016)

Asia Pacific survey of physicians on asthma and allergic rhinitis (ASPAIR): data from China
por: Hinds, David, et al.
Publicado: (2019)

Statin use and its effect on all-cause mortality of melanoma patients: a population-based Dutch cohort study
por: Livingstone, Elisabeth, et al.
Publicado: (2014)

Pazopanib: Approval for Soft-Tissue Sarcoma
por: Nguyen, Diana T., et al.
Publicado: (2013)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel, Pierre, et al.
Publicado: (2012)

Pazopanib induced hand-foot syndrome
por: Sundriyal, Deepak, et al.
Publicado: (2015)

Pazopanib-Induced Alopecia, an Underestimated Toxicity?
por: Biondo, Andrea, et al.
Publicado: (2015)

Pazopanib-Induced Severe Acute Pancreatitis
por: Kawakubo, Kazumichi, et al.
Publicado: (2015)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0cofo19vc0m28tovlmd1ofglee